Price$0.21+0.00 (+1.52%)
01:45 PM06:30 PM
News · 26 weeks96-81%
2026-03-012026-08-23
Mix6690d
- Other37(56%)
- Insider20(30%)
- SEC Filings8(12%)
- M&A1(2%)
Latest news
25 items- SECCosmos Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Cosmos Health Inc. (0001474167) (Filer)
- PRCosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program UnderwayHighest Q2 and H1 revenue in Company history, reflecting strength across all core segments and reaching a new milestone with an adjusted annualized revenue run-rate exceeding $75 millionContinued progress toward profitability targets, with adjusted gross profit reaching approximately $7.4 million on an annualized basis, adjusted gross margin expanding 165 basis points to 9.54%, and adjusted EBITDA improving 13.8%Demonstrated operating leverage and disciplined inventory management, with Q2 operating expenses growing at roughly half the rate of revenue and first-half inventory down 21.8% despite nearly 30% revenue growthStrengthened balance sheet, with total liabilities decreasing 13.3% by $6.
- SECSEC Form 10-Q filed by Cosmos Health Inc.10-Q - Cosmos Health Inc. (0001474167) (Filer)
- SECSEC Form NT 10-Q filed by Cosmos Health Inc.NT 10-Q - Cosmos Health Inc. (0001474167) (Filer)
- INSIDERChief Executive Officer Siokas Grigorios bought $70,000 worth of shares (349,825 units at $0.20), increasing direct ownership by 2% to 14,597,917 units (SEC Form 4)4 - Cosmos Health Inc. (0001474167) (Issuer)
- INSIDERChief Financial Officer Terzis Georgios was granted 328,407 shares, increasing direct ownership by 15% to 2,563,805 units (SEC Form 4)4 - Cosmos Health Inc. (0001474167) (Issuer)
- INSIDERChief Executive Officer Siokas Grigorios bought $140,000 worth of shares (766,284 units at $0.18), increasing direct ownership by 6% to 14,248,092 units (SEC Form 4)4 - Cosmos Health Inc. (0001474167) (Issuer)
- PRCosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B ChannelsDigital subscription platform brings together the Company’s proprietary consumer health products across consumer (B2C) and corporate (B2B) channelsCustomers can begin through one of three paths: a free nutritionist consultation, an AI-powered assistant, or building their own packageCorporate offering supports employee wellness programs and corporate gifting through multi-recipient management, tiered volume pricing, centralized billing, and dedicated account managementFuture platform enhancements are expected to include AI-driven personalization and the potential integration of at-home testing and diagnostic kitsPlatform builds on the U.S. subscription launch of NOOR Collagen, which has deliv
- SECSEC Form RW filed by Cosmos Health Inc.RW - Cosmos Health Inc. (0001474167) (Filer)
- PRCosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 UnitsCosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually Products are distributed across Albania and recommended by doctors and healthcare professionals, supporting broad consumer accessExpansion builds on the partnership launched in April 2025 and reflects Sky Premium Life's continued global growth CHICAGO, July 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced an expansion of its partnership with Pharma Cell for the distribution of its Sky
- SECSEC Form S-8 filed by Cosmos Health Inc.S-8 - Cosmos Health Inc. (0001474167) (Filer)
- PRCosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market RepurchasesCHICAGO, July 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 274,000 shares of its common stock in the open market at an average price of approximately $0.2554 per share. The Company has now repurchased a total of 5,112,000 shares for approximately $1.11 million under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with S
- SECCosmos Health Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Cosmos Health Inc. (0001474167) (Filer)
- PRCosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market RepurchasesCHICAGO, July 16, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 250,000 shares of its common stock in the open market at an average price of approximately $0.2782 per share. The Company has now repurchased a total of 4,838,000 shares for approximately $1.04 million under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with S
- PRCosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market RepurchasesCHICAGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 100,000 shares of its common stock in the open market at an average price of approximately $0.2928 per share. The Company has now repurchased a total of 4,588,000 shares for approximately $970,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Ru
- PRCosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market RepurchasesCHICAGO, July 14, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 133,000 shares of its common stock in the open market at an average price of approximately $0.298 per share. The Company has now repurchased a total of approximately 4,488,000 shares for approximately $941,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordanc
- PRCosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market RepurchasesCHICAGO, July 13, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 215,000 shares of its common stock in the open market at an average price of approximately $0.325 per share. The Company has now repurchased a total of 4,355,000 shares for approximately $901,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rul
- PRCosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in GreeceCosmos Health will supply DIABIT-IS X (sitagliptin), while Libytec handles distribution and promotion in GreeceFive-year agreement expected to contribute to revenue and cash-flow visibilityAs a prescription medicine, DIABIT-IS X is expected to be accessible to patients through Greece's national health insurance system, broadening its potential reachDIABIT-IS X is a generic alternative to Merck's Januvia®, which with Janumet® generated approximately $4.5 billion in combined global sales in 2022Positions Cosmos Health in the large and established European sitagliptin market CHICAGO, July 13, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a dive
- PRCosmos Health Launches Subscription ModelSubscription model already launched with NOOR Collagen in the United StatesEarly data shows a repeat purchase rate above 60% at high margins in excess of 50%Model is designed to drive stronger loyalty, greater lifetime value, and more predictable cash-flow visibilityCompany plans to extend the subscription model to additional Cosmos Health products globally, with further initiatives already underway CHICAGO, July 10, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has launched a subscription-based purchasing model for its proprietary consumer health brands.
- PRCosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market RepurchasesCHICAGO, July 09, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 80,000 shares of its common stock in the open market at an average price of approximately $0.2503 per share. The Company has now repurchased a total of 4,140,000 shares for approximately $831,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rul
- PRCosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market RepurchasesCHICAGO, July 08, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 190,000 shares of its common stock in the open market at an average price of approximately $0.2805 per share. The Company has now repurchased a total of 4,060,000 shares for approximately $811,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Ru
- PRCosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market RepurchasesCHICAGO, July 07, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 230,000 shares of its common stock in the open market at an average price of approximately $0.2539 per share. The Company has now repurchased a total of 3,870,000 shares for approximately $758,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Ru
- PRCosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share RepurchasesRecord Q2 2026 revenue of approximately $19.4 million, up approximately 31.5% year-over-year from $14.75 million in Q2 2025Record first-half 2026 revenue of approximately $37.3 million, up approximately 31% from $28.46 million in H1 20253,640,000 shares repurchased as of July 6, 2026 for approximately $700,000 under the Company's $5 million buyback program, with open market purchases ongoing CHICAGO, July 07, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided a business update on its second quarter and first-half revenue performance and share repurchase activity. Record
- PRCosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market PurchasesCHICAGO, July 06, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 220,000 shares of its common stock in the open market at an average price of approximately $0.2229 per share, continuing the buyback activity carried out under its ongoing repurchase program. The Company has now repurchased a total of 3,640,000 shares for approximately $700,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may buy back shares from time to time in the open market, through privately nego
- SECCosmos Health Inc. filed SEC Form 8-K: Other Events, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Cosmos Health Inc. (0001474167) (Filer)
COSM FAQ
5 questionsWhat does Cosmos Health Inc. do?
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products through its distribution channels and e-commerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece, and the United Kingdom; and warehousing facility. It serves wholesale pharmaceutical distributors and...Where does COSM stock trade?
Cosmos Health Inc. (COSM) is listed on NASDAQ.What sector and industry is COSM in?
Cosmos Health Inc. operates in the Health Care sector, Other Pharmaceuticals industry.What companies are similar to COSM?
Notable peers in the same industry include MCK (McKesson Corporation), COR (Cencora Inc.), CAH (Cardinal Health Inc.), ABC (AmerisourceBergen Corporation), CVET (Covetrus Inc.). Compare COSM side-by-side with any of them on Quantisnow.How can I track COSM on Quantisnow?
Quantisnow aggregates Cosmos Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COSM to receive live email and push alerts on every new disclosure.